Deerfield Management Company, L.P. (Series C) Sutro Biopharma, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 359,919 shares of STRO stock, worth $676,647. This represents 0.02% of its overall portfolio holdings.
Number of Shares
359,919Holding current value
$676,647% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.5 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$7.89 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.64 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.32 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $98.1M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...